All In Biotech

Drug Trial Radar · NCT06245408

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome With Moderate-to-Severe Symptom State (HZNP-DAZ-303)

Last checked: Nov 19, 2026Latest source record: Jan 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 434 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

434

Actual

Start

Apr 8, 2024

Primary completion

Oct 22, 2026

Study completion Dec 17, 2026

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Feb 7, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Primary Objective: To evaluate the effect of dazodalibep on patient-reported symptoms of SS in participants with moderate-to-severe symptom state Secondary Objectives: 1. To evaluate the effect of dazodalibep on patient-reported outcomes (PROs) in participants with SS. 2. To evaluate the effect of dazodalibep on measures of systemic activity, PROs, and salivary flow in participants with SS 3. To evaluate the safety and tolerability of multiple doses of dazodalibep in participants with SS

Conditions

  • Sjögren's Syndrome (SS)

Interventions

  • DazodalibepDrug

    IV infusion

  • PlaceboDrug

    IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in ESSPRI scoreTime frame: At Week 48
  2. Change from baseline in Diary for Assessing Sjogren's Patient Reported Index (DASPRI ) scoreTime frame: At week 48

Locations

194 sites in 26 countries. Site status is shown where the registry gives one.

  • Arizona Arthritis & Rheumatology Associates - Avondale

    Avondale, Arizona

  • Arizona Research Clinic PLLC

    Chandler, Arizona

  • Arizona Arthritis and Rheumatology Associates - Flagstaff - 399 S Malpais Ln

    Flagstaff, Arizona

  • Arizona Arthritis and Rheumatology Associates - Gilbert - 3645 S Rome St

    Gilbert, Arizona

  • Arizona Arthritis and Rheumatology Associates - Glendale - 5681 W Beverly Ln

    Glendale, Arizona

  • Arizona Arthritis and Rheumatology Associates - Tucson - 2001 W Orange Grove Rd

    Tucson, Arizona

  • Medvin Clinical Research - Covina

    Covina, California

  • UCSD Altman Clinical and Translational Research Institute Building

    La Jolla, California

  • Inland Rheumatology Clinical Trials Incorporated

    Upland, California

  • Medvin Clinical Research

    Whittier, California

  • Tekton Research, LLC - 2121 E Harmony Rd - PPDS

    Fort Collins, Colorado

  • Bradenton Research Center Inc

    Bradenton, Florida

  • Clinical Research of West Florida Inc - Clearwater

    Clearwater, Florida

  • West Broward Rheumatology Associates, Inc.

    Tamarac, Florida

  • BayCare Medical Group Primary Care and Rheumatology - Tampa

    Tampa, Florida

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Tufts Medical Center - Rheumatology Research Office - PPDS

    Boston, Massachusetts

  • Clinical Research Institute of Michigan, LLC-St. Claire Shores

    Saint Clair Shores, Michigan

  • Kansas City Physician Partners-8350 N Saint Clair Ave

    Kansas City, Missouri

  • Arthritis, Rheumatic & Bone Disease Associates - P

    Voorhees Township, New Jersey

  • Albuquerque Center for Rheumatology

    Albuquerque, New Mexico

  • NYU Langone Health - Joseph S. and Diane H. Steinberg Ambulatory Care Center

    Brooklyn, New York

  • Arthritis and Osteoporosis Consultants of The Carolinas

    Charlotte, North Carolina

  • Duke Early Phase Clinical Research Unit - PPDS

    Durham, North Carolina

  • Onsite Clinical Solutions, LLC - Salisbury

    Salisbury, North Carolina

  • Arthritis & Osteoporosis Center of Southwest Ohio - Miamisburg

    Miamisburg, Ohio

  • University of Toledo Medical Center

    Toledo, Ohio

  • STAT Research-600 Aviator Ct

    Vandalia, Ohio

  • Low Country Rheumatology PA-Summerville

    Summerville, South Carolina

  • Murfreesboro Medical Clinic Westlawn

    Murfreesboro, Tennessee

  • Amarillo Center For Clinical Research

    Amarillo, Texas

  • Accurate Clinical Management-Baytown

    Baytown, Texas

  • Precision Comprehensive Clinical Research Solutions

    Grapevine, Texas

  • R & H Clinical Research-777 S Fry Rd

    Katy, Texas

  • Texas Arthritis & Rheumatology Associates

    Katy, Texas

  • Valley Arthritis Center

    McAllen, Texas

  • University of Texas - San Antonio - Health Science Center - PPDS

    San Antonio, Texas

  • Advanced Rheumatology of Houston - The Woodlands

    The Woodlands, Texas

  • DM Clinical Research - Migraine and COPD - PPDS

    Tomball, Texas

  • Western Washington Medical Group

    Bothell, Washington

Showing 40 of 194 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.